Auvelity

Active Ingredient(s): Bupropion Hydrochloride + Dextromethorphan Hydrobromide
FDA Approved: * August 18, 2022
Pharm Company: * AXSOME
Category: Antidepressant
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Auvelity Oral Tablet, Multilayer, Extended Release
NDC: 81968-045
Labeler:
Axsome Therapeutics, Inc.